Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Neutralizing proprotein convertase subtilisin kexin type 9 (PCSK9) variants and uses thereof

Neutralizing proprotein convertase subtilisin kexin type 9 (PCSK9) variants and uses thereof

US Patent 9994923 · Granted Jun 12, 2018

Estimated economic value: $459,831,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-ASGR-1 monoclonal inhibitory antibodies2025
MAGEB2 binding constructs2025
Human IL-23 antigen binding proteins2024
Polynucleotides encoding monoclonal antibodies binding to human pituitary adenyl2024
Methods for treating a headache condition using anti-human PAC1 antibodies or an2022
PAC1 antibodies and uses thereof2020
Human IL-23 antigen binding proteins2018
Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)2018
Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)2018
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK92016
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK92016
Human IL-23 antigen binding proteins2016